Answers are grounded in this paper and cite their sources.
Purpose: Temporomandibular joint disorders (TMD) might be the main cause of the non-dental orofacial pain. Varioustreatment modalities were introduced to treat that condition. Low level laser therapy (LLLT) had an anti-inflammatory andanalgesic effect by enhancing the circulation and the cellular respiration. Synovial fluid-mesenchymal stem cells (SF-MSCs)had a regenerative and immunoregulatory effect. Both methods were applied as a treatment for the condition; but with nocomparative studies in the literature. So, the current study aimed at evaluating their therapeutic effects.Material and methods: A total of 27 patients with TMD in 40 TMJs were randomly divided into two equal groups. In group I,LLLT was applied at four successive weeks. For group II, SF-MSCs were isolated, proliferated and pooled at Passage 4 to beinjected into the joint space at four successive weeks.Results: SF-MSCs therapy was superior to the LLLT with regards to the enhancement of the maximum mouth opening and thereduction of the inflammatory cytokines IL-1β and TNFα. With regards to interleukin-6, there was no statistically significantdifference. However, for pain reduction, LLLT was better than SF-MSCs; but not after the third week.Conclusion: Both treatment methods are accepted modalities; but SF-MSCs were more superior and had more sustainedresults.
No takes yet. Share an insight, caveat, or question.
Mosaad Khalifah (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: